PortfoliosLab logo

Fate Therapeutics, Inc.

FATE
Equity · Currency in USD
ISIN
US31189P1021
CUSIP
31189P102
Sector
Healthcare
Industry
Biotechnology

FATEPrice Chart


Click Calculate to get results
S&P 500

FATEPerformance

The chart shows the growth of $10,000 invested in Fate Therapeutics, Inc. on Oct 2, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $117,810 for a total return of roughly 1,078.10%. All prices are adjusted for splits and dividends.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-15.02%
YTD-14.23%
6M60.34%
1Y170.42%
5Y105.21%
10Y38.87%

FATEMonthly Returns Heatmap


Click Calculate to get results

FATESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Fate Therapeutics, Inc. Sharpe ratio is 2.52. A Sharpe ratio higher than 2.0 is considered very good.

The chart below displays rolling 12-month Sharpe Ratio.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEDividends


FATE doesn't pay dividends

FATEDrawdowns Chart


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEWorst Drawdowns

The table below shows the maximum drawdowns of the Fate Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the {{portfolioName}} is 87.87%, recorded on May 19, 2016. It took 449 trading sessions for the portfolio to recover.


Depth
Start
To Bottom
Bottom
To Recover
End
Total
-87.87%Mar 27, 2014542May 19, 2016449Mar 2, 2018991
-45.8%Feb 27, 202013Mar 16, 202047May 21, 202060
-45.76%Oct 8, 201324Nov 8, 201376Mar 3, 2014100
-40.49%Jul 29, 201972Nov 6, 201946Jan 14, 2020118
-38.53%Jan 15, 202149Mar 26, 2021
-36.46%Mar 6, 2018102Jul 30, 201837Sep 20, 2018139
-32.27%Dec 6, 201812Dec 21, 201810Jan 8, 201922
-30.17%Oct 3, 201816Oct 24, 201827Dec 3, 201843
-24.22%Jan 11, 201919Feb 7, 201923Mar 13, 201942
-20.89%May 29, 201910Jun 11, 201912Jun 27, 201922

FATEVolatility Chart

Current Fate Therapeutics, Inc. volatility is 76.80%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Fate Therapeutics, Inc.


Loading data...

More Tools for Fate Therapeutics, Inc.